Which has grown faster, ENSG or IBRX?

Over the past five years, IBRX grew revenue faster — ENSG at a 17.08% CAGR versus IBRX at 202.97%.

Does ENSG or IBRX pay a bigger dividend?

ENSG pays a dividend (0.15% yield), while IBRX has no payments in the available dividend history.

Is ENSG or IBRX more profitable?

ENSG runs the higher net margin — ENSG at 6.90% versus IBRX at -598.56%.

How have ENSG and IBRX total returns compared?

Over the past 10 years, ENSG delivered 25.09% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

The Ensign Group, Inc. (ENSG) vs ImmunityBio, Inc. (IBRX)

A side-by-side comparison of The Ensign Group, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ENSG

The Ensign Group, Inc.

$10.08B

$172.89HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT

IBRX

ImmunityBio, Inc.

$10.38B

$9.91HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT

Total return — ENSG vs IBRX

growth of $100 · dividends reinvested · last 10y

ENSG +851.1% (+25.3%/yr)IBRX +41.8% (+3.6%/yr)ENSG compounded faster over this window

Log scale — wide-divergence pair

ENSG IBRX

ENSG vs IBRX: by the numbers

•IBRX is the larger company ($10.38B vs $10.08B market cap).
•ENSG is profitable (6.90% net margin) while IBRX runs a net loss (-598.56%).
•IBRX grew revenue faster over the past five years (202.97% vs 17.08% CAGR).
•ENSG pays a dividend (0.15% yield), while IBRX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ENSG	IBRX
P/E ratio	27.10	N/A
Forward P/E	22.18	N/A
PEG ratio	1.96	N/A
P/S ratio	1.84	62.60
P/B ratio	4.13	N/A
EV / EBITDA	20.73	N/A
FCF yield	4.16%	N/A

Profitability

Metric	ENSG	IBRX
Gross margin	14.14%	94.63%
Operating margin	8.52%	-226.00%
Net margin	6.90%	-598.56%
ROE	15.51%	N/A
ROIC	7.29%	-45.63%

Dividends

Metric	ENSG	IBRX
Dividend yield	0.15%	N/A
Payout ratio	4.04%	N/A

Growth (annualized)

Metric	ENSG	IBRX
Revenue CAGR (5Y)	17.08%	202.97%
EPS CAGR (5Y)	13.47%	N/A
FCF CAGR (5Y)	10.84%	N/A
Total return CAGR (5Y)	18.33%	0.39%

Frequently asked

Which has grown faster, ENSG or IBRX?: Over the past five years, IBRX grew revenue faster — ENSG at a 17.08% CAGR versus IBRX at 202.97%.
Does ENSG or IBRX pay a bigger dividend?: ENSG pays a dividend (0.15% yield), while IBRX has no payments in the available dividend history.
Is ENSG or IBRX more profitable?: ENSG runs the higher net margin — ENSG at 6.90% versus IBRX at -598.56%.
How have ENSG and IBRX total returns compared?: Over the past 10 years, ENSG delivered 25.09% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ENSG analysis Full IBRX analysis Interactive comparison tool

Dig into the metrics

Ensign P/E ratio Ensign dividend yield Ensign ROE ImmunityBio ROE Ensign operating margin ImmunityBio operating margin Ensign revenue growth ImmunityBio revenue growth Ensign free cash flow ImmunityBio free cash flow

Ensign & ImmunityBio appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.